Who
Raymond W. Cohen
Director
Company insider
Files Form 4 as: Director, Kestra Medical Technologies; Director, RxSight; Director, InspireMD; Chief Executive Officer, Axonics; Director, BioLife Solutions; Director, Spectrum Pharmaceuticals; Director, Cardiogenesis Corp /CA; Director, Cardiac Science.
In numbers
- Trades disclosed
- 191
- Buys
- 5
- Sells
- 36
- Bought
- $808K
- Sold
- $38.8M
- Companies
- 8
- Companies where not an officer
- 7
- First trade
- 1 May 2006
- Last trade
- 30 Sep 2026
- Last filed
- 1 Oct 2026
Companies traded
Activity over time
1 Nov 2024 – 1 Oct 2026
Buys above the line, sells below, each month.
Every trade
| Traded | Company | What | Amount | |
|---|---|---|---|---|
| 30 Sep 2026filed 1 Oct 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Sold | $98K3,330 at $29.28 | filing |
| 9 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —7,217 | filing |
| 9 Sep 2026filed 10 Sep 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —7,217 | filing |
| 17 Jun 2026filed 18 Jun 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —30,864 | filing |
| 17 Jun 2026filed 18 Jun 2026 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —30,864 | filing |
| 26 Mar 2026filed 30 Mar 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $200K10,000 at $19.98 | filing |
| 26 Mar 2026filed 30 Mar 2026 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $200K10,000 at $19.98 | filing |
| 14 Jan 2026filed 16 Jan 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Code A | —44,030 at $0.00 | filing |
| 14 Jan 2026filed 16 Jan 2026 | NSPR InspireMDMedical Devices | SEC FORM 4 Code A | —44,030 at $0.00 | filing |
| 4 Sep 2025filed 8 Sep 2025 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —10,909 | filing |
| 31 Jul 2025filed 4 Aug 2025 | RXST RxSightMedical Devices | SEC FORM 4 Code A | —35,668 at $0.00 | filing |
| 24 Jul 2025filed 24 Jul 2025 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Code A | —12,994 | filing |
| 7 Mar 2025filed 8 Sep 2025 | KMTS Kestra Medical TechnologiesMedical Devices | SEC FORM 4 Bought | $289K17,000 at $17.00 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonicsoption or derivative | SEC FORM 4 Code D | —31,125 at $0.00 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonicsoption or derivative | SEC FORM 4 Code D | $11.2M196,451 at $56.81 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonicsoption or derivative | SEC FORM 4 Code D | $7.4M106,776 at $69.37 | filing |
| 15 Nov 2024filed 15 Nov 2024 | Axonics | SEC FORM 4 Code D | $20.8M292,731 at $71.00 | filing |
| 24 Jul 2024filed 25 Jul 2024 | Axonicsoption or derivative | SEC FORM 4 Code M | —78,125 at $0.00 | filing |
| 24 Jul 2024filed 25 Jul 2024 | Axonicsoption or derivative | SEC FORM 4 Code M | —25,771 at $0.00 | filing |
| 24 Jul 2024filed 25 Jul 2024 | Axonics | SEC FORM 4 Code M | $366K25,771 at $14.19 | filing |
News
CAIRDAC Announces the Appointment of Raymond W. Cohen as Chairman of its Board of Directorsrecorder.ca · 24 Sep 2026
1 headline in the last 90 days name Raymond W. Cohen; 0 articles from the last 14 days about the 1 company they traded most, at most three about any one of them.